### **Overview** Max Healthcare Institute Ltd. continues to solidify its position as one of India’s leading private healthcare providers, combining clinical excellence with strategic growth, technological innovation, and digital transformation. As of November 2025, the company is in a robust expansion phase—driving both organic and inorganic growth—while enhancing patient outcomes, optimizing operations, and extending services beyond traditional hospital settings. With a nationwide clinical footprint, world-class infrastructure, and an evolving digital ecosystem, Max Healthcare is executing a multi-pronged strategy focused on **capacity expansion**, **clinical leadership**, **asset-light models**, **digital integration**, and **international patient growth**. --- ## **1. Core Operations & Network Strength (As of Nov 2025)** - **Hospital Network**: Operates **26 hospitals and medical centers** across **11 cities and 6 states**. - **Bed Capacity**: Over **5,100 operational beds**, with plans to add **more than 8,200 beds** over the next 4–5 years through greenfield, brownfield, and asset-light projects. - **Geographic Footprint**: Strong presence in Delhi NCR, Mumbai, Mohali, Dehradun, Lucknow, Nagpur, and expanding into Zirakpur, Thane, and other Tier I cities. - **Patient Reach**: Serves approximately **3.5 million patients annually** across primary to quaternary care. - **Network Occupancy**: Maintains a **74% system-wide hospital occupancy rate**, with most facilities operating above peer market averages. --- ## **2. Strategic Expansion & Growth Pipeline** ### **A. Recent Acquisitions & Integration (FY24–FY25)** Max Healthcare has successfully integrated key acquisitions, validating its M&A capabilities: - **Jaypee Hospital, Noida** (500 beds): Fully acquired in Nov 2024. Already achieving strong performance metrics with ~57% occupancy and an ARPOB of ~₹52,000 pre-acquisition. Expected to perform in line with top-tier Max facilities. - **Sahara Hospitals, Lucknow** (400+ beds): Acquired for ₹993 crore. Currently 244 beds operational, with plans to expand to 450+ beds. - **Alexis Hospital, Nagpur** (200 beds): Acquired for ₹395 crore. Now Max Super Specialty Hospital Nagpur, the only JCI-accredited hospital in the city. > 📈 **Post-Acquisition Performance**: Acquired hospitals in Lucknow and Nagpur reported **67% and 118% YoY EBITDA growth**, respectively, within nine months. The integration of 550+ beds contributed to **41% revenue growth and 96% EBITDA growth in FY25**, with minimal capital outlay. --- ### **B. Asset-Light & Built-to-Suit Expansion Strategy** Max Healthcare is accelerating growth through **asset-light models**—leveraging partnerships with developers to build hospitals on their land under long-term lease (built-to-suit), significantly improving **Return on Capital Employed (ROCE)**. **New Projects Underway (3,900+ beds in 3–4 years):** - ✅ **Max Dwarka, Delhi**: 303-bed tertiary-care facility launched in July 2024. Achieved **EBITDA breakeven within 6 months**—a testament to the asset-light model’s efficiency. - ✅ **Thane, Mumbai**: 500-bed hospital on 6 lakh sq. ft. under development; expected commissioning by 2028. - ✅ **Zirakpur, Mohali**: 400-bed hospital (upgraded from initial 250-bed plan), under development with structural work ongoing. - ✅ **Pitampura, Delhi**: 200-bed facility in development. - ✅ **Dehradun**: 130-bed oncology-focused hospital leased near existing 220-bed facility; operations to begin in 2028. - ✅ **Sector 128, Noida & Mohali Greenfield Tower**: 160 beds at Mohali nearing commissioning. > 💡 **ROCE Focus**: Asset-light models yield **>45% ROCE**, compared to ~35% in brownfield expansions. Developers bear cost and time overruns, allowing Max to scale faster with lower execution risk. --- ### **C. Brownfield & Greenfield Expansions** - **Brownfield Additions**: Over 1,264 beds added organically via reconfiguration and expansions. - **Major Expansion Sites**: Patparganj (Delhi), Saket, Gurugram, Mumbai, Vaishali (brownfield expansion underway with completion in 30 months). - **Future Capacity Additions (Next 3–4 Years)**: - Gomti Nagar Lucknow: +900 beds - Gr. Mohali: +500 beds - Gr. Noida: +400 beds - Sec. 53 & Sec. 128, Gurgaon: +500 each - Delhi NCR: +500 beds --- ## **3. Clinical & Technological Leadership** ### **A. Advanced Medical Technology** Max has deployed cutting-edge equipment, reinforcing its position in **tertiary and quaternary care**: - **26 Robotic Surgical Systems**, including **Da Vinci Xi** and **Versius**, enabling minimally invasive precision surgeries across urology, gynaecology, GI, and transplants. - **EDGE with HyperArc™ Radiosurgery**: Globally advanced system for submillimeter precision in brain, spine, and lung tumors. - **StealthStation™ S8**: Real-time 3D imaging for neurosurgery and spine navigation. - **AI-Driven Diagnostics**: Qure.ai, Brainsight.ai, Annalise.ai, and BonExpert for radiology and orthopedics. - **Mako Robotic Arm**: For knee and hip replacements; **Excelsius GPS** for spinal surgery. > 🔬 **Clinical Milestones (2025)**: > - World-first **in-situ reduction of small intestinal graft** (Nanavati Max). > - **Robotic-assisted kidney transplant** using spouse donor (MSSH Noida). > - Successful **UBE spine surgery** program launched at BLK Max. --- ### **B. Centers of Excellence** Core specialties: **Oncology, Cardiac Sciences, Neurosciences, Transplants, Orthopaedics**. - Performs **1,600+ transplants**, **6,600+ robotic surgeries**, and **48,000+ cardiac procedures** annually. - Home to **Asia’s largest bone marrow transplant program**. - Expanding **oncology services** with new radiation units and dedicated daycare blocks. --- ## **4. Digital Transformation & Innovation** ### **Max MyHealth: Proprietary Digital Platform** - **Patient Registrations**: Over **1.1 million** (as of Aug 2025). - **Monthly Active Users**: 1.13 lakh, with **~29% of Q1 FY26 revenue** from digital channels (online marketing, web appointments). - **Features**: - Video consultations, appointment booking, medical records access, OPD command center. - Integration with Max@Home, Max Lab, diagnostics, and teleconsultation. - AI-driven PROM (Patient Reported Outcome Measurement) tool for early detection of post-op complications. ### **Digital Infrastructure Enhancements** - **OPD Command Centre**: Real-time patient flow optimization; reduces outpatient waiting times. - **GenAI & AI Co-development**: Collaborations with **IIT Bombay, IIT Delhi, Columbia University** on AI for radiology, orthopaedics, and oncology. - **Data Lake**: Enables personalized care planning, predictive analytics, and operational efficiency. --- ## **5. Adjacent Businesses: Max Lab & Max@Home** ### **Max Lab** - Operates in **57 cities**, with **23 company-owned** and **500+ partner-run collection centers**. - Conducted **over 2 million diagnostic tests**, offering **2,600+ tests**, including **molecular, genomic, and companion diagnostics**. - Revenue mix: **32% YoY growth** in *Well-Wise* wellness packages. - Digital Push: - E-commerce via **WhatsApp** and **dedicated app**. - Cloud-based mobile app for phlebotomists with GPS tracking and digital payments. - Phased rollout of iOS/Android patient app. ### **Max@Home** - One of India’s **largest organized home healthcare providers**, with **240,000+ patients served** in 15 cities. - Offers: **Palliative care, post-operative monitoring, dialysis, physiotherapy, pathology, ICU-at-home**. - Achieved **34–35% CAGR**, processing **3,000+ daily billed transactions**. - Accredited by **QAI (ISQua member)**; operates medical outposts in **120+ corporate/school locations**. > 💡 **Market Opportunity**: Home healthcare in India is **~3.6% of total health spend** vs. 8.3% in the US, indicating significant growth runway. --- ## **6. International Expansion & Medical Tourism** - **Medical Value Travel (MVT)**: Contributing **9–10% of total revenue**, growing at **20% CAGR**. - **Patient Sourcing**: Kenya, UAE, Oman, Ethiopia, Bangladesh, Iraq, Uzbekistan, Myanmar. - **Cost Advantage**: Procedures cost **67–91% less** than global rates: - Heart bypass: **₹4 lakhs (~$5,200)** vs. global **$51,630**. - Hip replacement: **₹7 lakhs (~$8,500)** vs. **$21,000**. - **Patient Assistance Centers (PACs)**: 16 global offices (company-owned and partner). - **PAC in Bangladesh**: Initially disrupted due to political instability, but expected to contribute meaningfully soon. --- ## **7. Research & Academia** - **Research Ecosystem**: - 108 active **clinical trials**, 29 **grant studies**, 650+ **active research projects**. - Published **2,800+ research papers**, including over 400 in peer-reviewed journals in FY25. - Secured **₹4.5 crore** in national & international grants (e.g., ICMR, Pfizer). - **Academic Training**: - **MIME (Max Institute of Medical Excellence)** and **MIAPE**, training **120,000+ medical students** and **3,500 paramedics** via 290 structured courses. - Partnerships with **Imperial College London**, **IITs**, and **Lincoln American University**. --- ## **8. Financial Performance (FY25–FY26 Indicators)** - **Gross Revenue (FY25)**: ₹9,065 crore (+26% YoY). - **EBITDA (FY25)**: ₹2,319 crore (+21.6% YoY). - **Digital Revenue Contribution**: 29% in Q1 FY26. - **M&A Efficiency**: Acquisitions funded via **QIP, internal accruals**, and **no additional debt**, preserving capital structure.